Table 4.
Clinical Features | Laboratory features | 2023 ACR/EULAR APS Criteria Status | Revised Sapporo APS Criteria Status | |
---|---|---|---|---|
Patient 1 | Arterial thrombosis without a high-risk CVD profile | Moderate positive IgM aβ2GPI | Laboratory domain score is inadequate | Classified as APS |
Patient 2 | Arterial thrombosis with a high-risk CVD profile and Early fetal death (10w–15w 6d) | Moderate positive IgM aβ2GPI | Laboratory domain score is inadequate | Classified as APS |
Patient 3 | Arterial thrombosis without a high-risk CVD profile and thrombocytopenia | Persistent positive LAC | Classified as APS | Classified as APS |
Patient 4 | Arterial thrombosis with a high-risk CVD profile | Persistent positive LAC | Clinical domain score is inadequate | Classified as APS |
Patient 5 | Arterial thrombosis with a high-risk CVD profile | Persistent positive LAC | Clinical domain score is inadequate | Classified as APS |
Patient 6 | Venous thromboembolism with a high-risk VTE profile | Persistent positive LAC | Clinical domain score is inadequate | Classified as APS |
Patient 7 | Venous thromboembolism with a high-risk VTE profile | Persistent positive LAC | Clinical domain score is inadequate | Classified as APS |
aβ2GPI; anti-beta2glikoprotein I, APS; antiphospholipid syndrome, CVD; cardiovascular disease, LAC; lupus anticoagulant, VTE; venous thromboembolism.